| Company | Date | Position | Consensus β | Price Target β | 2-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
RMD
Resmed
|
Oct 30, 2026 | BUY |
Buy
+4.6% avg upside
27 analysts
|
$270.00
17.32% Upside
|
+2.5% | Β· |
|
GEHC
GE Healthcare Technologies Inc
|
Oct 29, 2026 | BUY |
Strong Buy
+10.2% avg upside
23 analysts
|
$90.00
17.50% Upside
|
+9.4% | Β· |
|
GKOS
Glaukos
|
Oct 29, 2026 | BUY |
Strong Buy
-18.6% avg upside
21 analysts
|
$225.00
5.30% Downside
|
-7.4% | Β· |
|
BSX
Boston Scientific
|
Oct 29, 2026 | BUY |
Strong Buy
+43.0% avg upside
38 analysts
|
$50.00
19.15% Upside
|
+5.0% | Β· |
|
AXGN
AxoGen
|
Oct 29, 2026 | BUY |
Strong Buy
-17.4% avg upside
21 analysts
|
$65.00
31.75% Upside
|
+1.5% | Β· |
|
MDXG
MiMedx Group
|
Oct 29, 2026 | BUY |
Strong Buy
+168.0% avg upside
17 analysts
|
$7.00
80.46% Upside
|
-16.1% | Β· |
|
ISRG
Intuitive Surgical
|
Oct 21, 2026 | HOLD |
Strong Buy
+12.0% avg upside
37 analysts
|
$400.00
7.51% Downside
|
+5.1% | Β· |
|
TFX
Teleflex
|
Oct 13, 2026 | HOLD |
Buy
+31.3% avg upside
20 analysts
|
$140.00
0.24% Upside
|
+24.3% | Β· |
|
CH:ALC
Alcon
|
Oct 13, 2026 | BUY |
Strong Buy
+19.4% avg upside
36 analysts
|
$65.66
11.10% Upside
|
+14.8% | Β· |
|
INSP
Inspire Medical Systems
|
Oct 13, 2026 | BUY |
Buy
+30.4% avg upside
21 analysts
|
$75.00
10.12% Upside
|
-9.5% | Β· |
|
PLSE
Pulse Biosciences
|
Oct 13, 2026 | BUY |
Strong Buy
+19.3% avg upside
8 analysts
|
$55.00
5.23% Upside
|
+9.3% | Β· |
|
LNTH
Lantheus
|
Oct 13, 2026 | HOLD |
Buy
-19.7% avg upside
21 analysts
|
$109.00
8.48% Upside
|
+1.6% | Β· |
|
TNDM
Tandem Diabetes Care
|
Oct 13, 2026 | HOLD |
Buy
+64.3% avg upside
29 analysts
|
$18.00
5.78% Downside
|
+11.5% | Β· |
|
DXCM
Dexcom
|
Oct 13, 2026 | BUY |
Strong Buy
+31.4% avg upside
33 analysts
|
$100.00
21.59% Upside
|
-6.0% | Β· |
|
HAE
Haemonetics
|
Oct 09, 2026 | BUY |
Strong Buy
-20.9% avg upside
18 analysts
|
$140.00
17.07% Upside
|
+1.0% | Β· |
|
MMED
MiniMed Group, Inc.
|
Oct 08, 2026 | BUY |
Strong Buy
+37.6% avg upside
17 analysts
|
$28.00
53.20% Upside
|
-15.6% | Β· |
|
COO
Cooper Co
|
Sep 11, 2026 | BUY |
Buy
+105.8% avg upside
21 analysts
|
$75.00
25.97% Upside
|
+18.6% | Β· |
|
MDT
Medtronic
|
Sep 02, 2026 | BUY |
Buy
+4.4% avg upside
38 analysts
|
$115.00
19.19% Upside
|
+10.7% | Β· |
|
LIVN
LivaNova
|
Aug 21, 2026 | BUY |
Strong Buy
+1.1% avg upside
15 analysts
|
β | +16.1% | Β· |
|
NPCE
NeuroPace
|
Jul 28, 2026 | BUY |
Strong Buy
+46.9% avg upside
14 analysts
|
$22.00
78.91% Upside
|
-18.4% | Β· |
|
FOCL
FocalTherics
|
Jul 17, 2026 | BUY |
Buy
+103.3% avg upside
8 analysts
|
$15.00
258.86% Upside
|
-39.0% | Β· |
|
ADMA
ADMA Biologics
|
Jul 15, 2026 | BUY |
Strong Buy
-3.8% avg upside
15 analysts
|
$17.00
48.95% Upside
|
+46.2% | Β· |
|
ESTA
Establishment Labs Holdings
|
Jul 15, 2026 | BUY |
Strong Buy
+45.5% avg upside
13 analysts
|
$105.00
68.02% Upside
|
-24.4% | Β· |
|
SENS
Senseonics Holdings
|
Jul 15, 2026 | BUY |
Buy
+58.2% avg upside
13 analysts
|
$18.00
89.35% Upside
|
+94.8% | Β· |
|
EW
Edwards Lifesciences
|
Jul 15, 2026 | BUY |
Strong Buy
+10.0% avg upside
35 analysts
|
$105.00
14.12% Upside
|
+18.5% | Β· |
|
STAA
Staar Surgical
|
May 14, 2026 | HOLD |
Buy
+42.3% avg upside
16 analysts
|
$27.00
10.00% Upside
|
-24.2% | Β· |
|
MNKD
MannKind
|
May 07, 2026 | BUY |
Buy
+104.0% avg upside
22 analysts
|
$7.00
100.06% Upside
|
+9.9% | Β· |
|
EMBC
Embecta Corporation
|
May 06, 2026 | HOLD |
Sell
+60.0% avg upside
5 analysts
|
$5.00
20.00% Downside
|
+80.8% | Β· |
|
ABT
Abbott Laboratories
|
Apr 20, 2026 | HOLD |
Strong Buy
+8.5% avg upside
36 analysts
|
$115.00
8.24% Upside
|
+16.0% | Β· |
|
TEM
Tempus AI, Inc. Class A
|
Apr 13, 2026 | BUY |
Strong Buy
-0.3% avg upside
25 analysts
|
$100.00
38.49% Upside
|
+77.0% | Β· |
|
GH
Guardant Health
|
Jun 13, 2025 | BUY |
Strong Buy
-3.1% avg upside
33 analysts
|
$65.00
63.73% Downside
|
+215.2% | Β· |
|
ZBH
Zimmer Biomet Holdings
|
Nov 05, 2021 | BUY |
Buy
+20.5% avg upside
39 analysts
|
$175.00
85.11% Upside
|
-19.7% | Β· |
|
LMAT
Lemaitre Vascular
|
Sep 16, 2021 | BUY |
Strong Buy
+21.2% avg upside
16 analysts
|
$70.00
13.56% Downside
|
+0.2% | Β· |
|
TELA
TELA Bio
|
Aug 11, 2021 | BUY |
Strong Buy
+824.3% avg upside
9 analysts
|
$20.00
2368.91% Upside
|
-30.9% | Β· |
|
TARS
Tarsus Pharmaceuticals
|
Aug 10, 2021 | BUY |
Strong Buy
+9.9% avg upside
17 analysts
|
$45.00
39.97% Downside
|
-31.3% | Β· |
|
IART
Integra Lifesciences
|
May 20, 2021 | BUY |
Buy
+208.1% avg upside
22 analysts
|
$86.00
574.45% Upside
|
-29.8% | Β· |
|
CTSO
Cytosorbents
|
Sep 17, 2020 | BUY |
Strong Buy
+178.6% avg upside
14 analysts
|
$15.00
230.34% Upside
|
Β· | Β· |
|
VREX
Varex Imaging
|
Aug 13, 2020 | HOLD |
Hold
+8.3% avg upside
10 analysts
|
$18.00
2.33% Downside
|
+73.9% | Β· |
|
VRAYQ
Viewray
|
Dec 03, 2019 | BUY |
Strong Buy
+558333233.3% avg upside
12 analysts
|
$7.00
699999899.98% Upside
|
Β· | Β· |
|
ARAY
Accuray
|
Aug 17, 2018 | BUY |
Buy
+4430.1% avg upside
9 analysts
|
$6.00
4185.78% Upside
|
Β· | Β· |
|
OSIS
OSI Systems
|
Aug 25, 2017 | BUY |
Strong Buy
+6.3% avg upside
11 analysts
|
$93.00
53.33% Downside
|
+20.3% | Β· |
|
PRGO
Perrigo Company
|
Aug 02, 2016 | HOLD |
Hold
+333.3% avg upside
20 analysts
|
$97.00
514.61% Upside
|
-13.2% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.